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Introduction    
 
INTRODUCTION 
                                       
Type 2  diabetes  is   the  predominant  form  of   diabetes 
worldwide,    accounting   for   90%    of    cases    globally.    An    
epidemic   of Type 2  diabetes   is  underway  in  both  developed  and  
developing countries. Globally   the  number  of  Type  2  DM  is  
expected  to  rise  from  the  current estimate   of   150  to  million  in  
2010  and  300  million  in   2025.  So  Type   2 DM   has   become   one   
of    the   world’s    most    important    public   health problems. DM    
both   insulin   dependent   and   non-insulin dependent is a   risk    factor   
for   CAD, accounting    for    14%- 50%   of   new   cases of CAD. CAD   
is   the  most common  cause of  death in  adults  with  DM. In diabetes  
the   incidence   of   CAD   relates   to   the   duration   of   DM, level  of  
glycemic control  and  its  pathogenesis  involve  endothelial  dysfunction  
and  Increased lipoprotein peroxidation,  increased  inflammation,  
prothrombotic  state   and associated metabolic abnormalities. 
(19)
Increased activity of hypothalmopituitary axis and elevated   cortisol 
level may underlie metabolic syndrome and coronary artery disease in 
patients with Type 2DM.  People with Type 2DM are at increased risk of 
cardiovascular disease risk and hyperactive hypothalmopituitary  axis 
thus suitable for study of association of cortisol level with cardiovascular 
risk
(6)
. 
  
 
 
 
 
 
 
 
 
 
Aims & Objectives          
AIM OF STUDY 
To  analyze  the  association  of  Cortisol  level  and  prevalence  of  
coronary artery  disease  in  patients  with  TYPE  2  DIABETES 
MELLITUS. 
   
 
 
 
      
 
 
 
 
  
 
 
 
Review of Literature            
 
REVIEW OF LITERATURE 
Diabetes Mellitus 
 DM is characterized by chronic hyperglycemia, with the 
disturbance of fat, protein metabolism resulting from defects in insulin 
secretion, action or both. When fully expressed DM is characterized 
fasting hyperglycemia but disease can also be recognized during less 
overt stages most usually by presence of glucose intolerance. Effects of 
DM include long term damage, dysfunction and failure of various organs 
especially eyes, kidneys, heart and blood vessels. DM may present with 
characteristic symptoms such as thirst, polyuria, blurring of vision, 
weight loss and polyphagia. In its most severe forms with ketoacidosis or 
non ketotic hyperosmolarity which is in the absence of effective treatment 
leads to stupor, coma and death
(3).
 
Clinical Stages 
 Individuals who ultimately develop DM pass through several 
clinical stages during its development, initially glucose regulation is 
normal and no abnormality of glycemia can be identified even if this 
individuals undergo an oral glucose tolerance test.This stage is followed 
by period of variable duration in which glucose regulation is 
impaired.Diabetes itself is characterized by either fasting glycemia or 
marked abnormalities of glucose tolerance or both. If insulin is required 
to prevent ketosis such patients are designated as insulin dependent 
diabetes. In all forms of DM there may be remission in the extent of 
hyperglycemia patient may revert to have impaired glucose regulation or 
even normal glycemia, particularly if diabetes is recent in onset. 
Gestational diabetes is often followed by impaired glucose tolerance 
following parturition and a variable period such women may be 
normoglycemic with subsequent pregnancy gestational diabetes is likely 
to recur. Many women who have had GDM develop diabetes within few 
years.  
 
Type 2DM is the most common form of diabetes. It is 
characterized by disorders of insulin action and secretion either of which 
may be the predominant feature. Usually both are present at the time 
diabetes become clinically manifested although specific etiology of this 
form of diabetes is not known although, autoimmune destruction of beta 
cells does not occur. The patients with Type 2DM usually have insulin 
resistance and relative rather than absolute insulin deficiency. At the time 
of diagnosis of diabetes and often throughout there lifetime in these 
patients do not need insulin treatment to survive, although ultimately 
many require it for glycemic control.Most patients with diabetes are 
obese and they develop diabetes and obesity aggravates the insulin 
resistance. Type 2DM frequently goes undiagnosed or many years 
because hyperglycemia develops gradually and in the earlier stages it is 
not severe enough to produce classic symptoms of diabetes ,however 
such patients are at increased risk of developing micro vascular and 
macrovascular complications. There circulating insulin may be normal or 
elevated yet insufficient to control blood glucose levels within normal 
range because of the insulin resistance. Insulin resistance may improve 
with weight reduction or pharmacological treatment and results in 
normalization of patients glycemia. The risk of developing type 2DM 
increases with age, obesity and physical inactivity. Type2DM shows 
strong familial aggregation so that person with a parent or sibling with 
disease are at increased risk, as are individuals with obesity, SHT, 
Dyslipedemia and women with history of gestational diabetes. The 
frequency of Type 2DM varies considerably among different racial or 
ethinic sub groups. Persons of native Americans, 
Polynesians,Micronesian ,Asian Indians, Hispanics or African Americans 
descent are at higher risk than persons of European Origin. Although the 
disease is most commonly seen in adults, the age o onset tends to be 
earlier in persons of non-European origin
(3)
. 
 
Epidemiology of Diabetes Mellitus  
 The number of persons in a particular place at a particular time 
who have DM, expressed as a proportion, this number is commonly 
called the prevalence rate or preferably the prevalence. The incidence rate 
is the number of new cases. The rate of type 2 DM is increasing steadily 
with age,with an almost 100 fold increase from early childhood to old 
age. There are two peaks of occurrence o Type I DM. one centered in 2
nd
 
decade and other in the 6
th
 and 7
th
 decades.Type one diabetes have 
considered the disease occurrence in children,typically under the age of 
15 years.Type I DM rarely occurs during the 1
st
 year of life. The 
incidence rises sharply until the age of 12 to 14 years and then declines. 
The incidence of Type I DM with onset after the age of 30 years are 
rare
(4)
. 
 
Insulin Resistance 
 Generally refers to the resistance to the metabolic effects of insulin, 
including suppressive effects of insulin on endogenous glucose 
production,  
stimulatory effects on peripheral glucose uptake and glycogen synthesis, 
inhibitory effects of insulin on adipose tissue lipolysis. The mortality and 
morbidity of Type 2 DM associated with insulin resistance. Insulin 
resistance predates the onset of Type 2 DM by 10-12 years and is the best 
clinical predictor of subsequent development of Type 2 DM
(4)
. 
 
Metabolic Syndrome 
 Reaven formally recognized the clinically significant association 
between insulin resistance and cardiovascular risk actors. NCEP and ATP 
III in 2001 gives criteria as plasma glucose levels more than 110 mg/dl, 
visceral Obesity (more than 35 inches in women, more than 40 inches in 
men), SHTN(130/85 mm of Hg),Hypertriglyceridemia more than 150 mg 
/dl, HDL less than 40 mg/dl in men and less than 50 mg/dl in women, 3 
of the following criteria fulfills metabolic syndrome. Other recognized 
syndrome include systemic inflammation, a prothrombotic state, 
increased oxidant stress. Increased circulating levels of TNF alpha, IL-6 
and other pro inflammatory cytokines may contribute to some of the 
metabolic features of metabolic syndrome , whereas increased levels of 
Plasminogen Activator Inhibitor – 1(PAI-1) appears to heighten the risk 
of atherothrombosis. Increased risk of atherosclerotic disease mortality 
and morbidity is conferred by metabolic syndrome
(4)
. 
 
Maturity Onset Diabetes Mellitus 
 By definition, a family is considered to have early onset diabetes if 
at least one and ideally two members of family are diagnosed with 
diabetes before the age of 20. Patient are considered non insulin 
dependent I if 5 years after the diagnosis they either are not receiving 
Insulin treatment or are insulin treated but have significant levels of 
circulating C-Peptide. Autosomal dominant inheritance beta cell 
dysfunction rather than insulin resistance is characteristic of MODY. 
Subjects with MODY mutation do not need to be obese to develop 
diabetes, in marked contrast to early onset type 2DM. 
 
Type 2DM and epidemic of CAD 
 Type 2 DM is multifactorial disease and shows heterogeneity in 
numerous respects. Type 2DM is a descriptive term and manifestation 
include metabolic syndrome, cluster of CAD risk factors, glucose 
intolerance , hyperinsulinemia,dyslipidemia , SHT, visceral Obesity , 
hypercoagulability and microalbuminuria
(4)
. 
 Mechanisms for microvascular pathology in Diabetes 
 The partial loss of insulin effects due to dysfunction or the 
destruction of beta cells or peripheral insulin resistance and ensuing 
hyperglycemia and other disturbance of metabolism have profound 
consequence on cellular function , Extracellular matrix , organ function 
and whole body physiology. Microvascular dysfunction and pathology 
may be initiated by hypertension. The glomerular hypofilteration 
observed in DM may be caused in part by systemic Hypertension. 
Mechanism that has been described that link mechanical forces to 
vascular dysfunction including pressure, stretch and shear stress. 
Overactivity of sympathetic nervous system can be a participating factor 
in the development of hypertension in both Type 2DM. Insulin is thought 
to have vasoconstrictor effects through activation of sympathetic nervous 
system
(5)
. 
 Modification of extracellular and intracellular proteins by sugars 
can result in formation of AGEs, which is virtually irreversible. The most 
prevalent AGE is carboxy methyl lysine. Because of there long turnover 
rate structural extracellular protein such as collagen are particularly 
susceptible to AGE modification. AGE has been demonstrated in 
numerous tissues in both types of diabetes, such as retina and the 
glomeruli. AGEs may interfere with vascular signaling by facilitating 
breakdown nitric oxide.AGE may impair the functioning of intracellular 
protein as in the case of reduced activity of basic fibroblast growth factor 
in endothelial cells. AGE also alters the properties of extracellular matrix. 
Glcosylation of collagen type IV renders it resistant to degradation by 
MMP. AGE crosslinking of type I collagen expands the packing of 
collagen molecules. Modification of type IV collagen decreases 
endothelial cell adhesions. Stimulation of AGE receptor can lead to trans 
differentiation of renal tubular epithelial cells to myofibroblasts, Which 
may be responsible for accumulation of extracellular matrix. 
 Typical elements of inflammatory process are evident in the 
vasculature of diabetes. Increased expression of vascular adhesion 
molecules leading recruitment of leucocytes to vascular walls is regarded 
as pivotal event in early inflammation. Blocking intracellular adhesion 
molecule-1(ICAM-1) prevents leukostasis and retinal leakage. The 
proinflammatory cytokine TNF-alpha is also important in pathology
(5)
. 
 
 Pathogenesis of cardiovascular disease in Diabetes Mellitus  
  DM is a major independent risk factor for cardiovascular disease. 
Increased prevalence of CAD in diabetes has been attributed in large part 
to the acceleration of coronary atherosclerosis, which occurs at an earlier 
age and advances more rapidly to clinical cardiovascular events in 
individuals with diabetes than those without diabetes. The patients with 
diabetes are also prone to arterial thrombosis due to persistently activated 
thrombogenic pathway and impaired fibrinolysis. Histopathological study 
of atherotomy specimen from diabetic patients showed two fold increase 
in PAI-1 and decrease in the level of immunoreactive urokinase 
Plasminogen activator. Macrophage infiltration also elevated nearly two 
folds. Morphometric analysis of coronary atherectomy specimen from 
primary lesions has indicated that relative amounts of collagen rich and 
hypercellular plaque components, which comprised approximately 90% 
of the total area were similar in DM and non DM subjects. Coronary 
artery calcification in diabetic subjects appears either similar or increased 
compared to that in non diabetic subjects. The atherogenic effects of 
diabetes and insulin resistance appaears to be initiated by combination of 
metabolic abnormalities related to hyperglycemia , impaired insulin 
action or insulin deficiency , a prothrombogenic dyslipedemia and 
comfounding factors such as hypertension and obesity. Vasoactive 
hormones, cytokines and growth factors such as angiotensin II , TNF-
alpha and vascular endothelial growth factor amplify and in part mediate 
the adverse vascular effects of these metabolic abnormalities . The 
metabolic and hormonal imbalance can induce endothelial dysfunction, 
vascular inflammation, intimal lipid accumulation, fibrosis and 
hypercoagulability leading to atherosclerosis and thrombosis. 
Thrombosis is the major cause of stenosis and sudden death. 
Intramural arterial thrombosis can be triggered by the disruption of 
complex plagues, which expose the blood to thrombogenic factor that are 
enriched in the sub endothelial area. The tissue factor the major activator 
of the extrinsic coagulation pathway is highly expressed in the plague 
core. Disruption of the plaque surface allows this tissue factor to bind 
circulating factor VII in the blood to activation of coagulation cascade 
and formation of clot. Elevated levels of tissue factor in vascular tissues 
in diabetic and obese insulin resistant patients may predispose to the 
activation of coagulation cascade. More over increased arterial expression 
of PAI in diabetes may impair the dissolution of nascent thrombi. 
 Diabetes has number of adverse effects on vascular endothelium 
that impair these functions and likely to facilitate atherosclerosis and 
thrombosis. Diabetes increases the expression of leukocyte adhesion 
molecules that mediate binding and the infiltration of monocytes into the 
arterial subendothelial space. Diabetes impairs endothelial barrier 
functions which increase transendothelial permeability and access of 
circulating molecules to vascular interstitium. Diabetes also alters the 
endothelial cell synthesis of a host of vascular hormones and factor that 
affect vascular tone, hemodynamics and coagulation.         
Arterial stiffness is strongly associated with atherosclerosis. 
Increased glycation of ECM proteins such as collagen and elastin may 
increase covalent intermolecular cross linking and there by reduce 
elasticity. Increase arterial stiffness may also result from arterial 
calcification, arterial wall thickening or increased chronic vascular 
smooth muscle cell contraction due to an imbalance in vasoactive 
hormone activities. Impaired arterial elasticity might contribute to 
atherogenesis by increasing mechanical and shear forces causing 
endothelial damage, activation stretch activated mechanoreceptors and 
increased release of trophic factors. 
Hyperglycemia, plasma insulin and insulin resistance, elevated 
lipids and lipoprotein , circulating adhesion molecules, elevated 
Plasminogen activator inhibitor-1, C-reactive protein, fibrinogen, 
hyperhomocystenemia ,hypertension all contribute to CAD in type II 
DM
(6)
.  
Cortisol 
 Three mains type of hormones are produced by adrenal cortex, 
glucocorticoids(cortisol,corticosterone),minerelocoticoids(aldosterone,de
oxycorticosteroids) and sex steroids. All steroids hormones are derived 
from the cyclopentanoperhydrophananthrene structure that is 3 cyclo 
hexane rings and single cyclopentane ring. Glucocorticoids are secreted 
in relatively high amounts (cortisol 10-20 mg/day) from zona fasciculata 
of adrenal cortrex under the control of ACTH. Classical endocrine 
feedback loops are in place to control the secretion of both hormones. 
Cortisol inhibits the secretion of CRH and ACTH form the hypothalamus 
and pituitary respectively. Aldosterone induced sodium retention inhibits 
renal rennin secretion. 
 
 
Effects of Glucocorticoids 
 Glucocorticoids  increase  blood  glucose  concentration  through  
their  action on glycogen,  protein  and  lipid  metabolism . In  the  liver  
cortisol  stimulates  glycogen  deposition  by  increasing  glycogen  
synthase, and  inhibiting glucogen mobilizing  enzyme  glycogen 
phosphorylase. Hepatic glucose output increases throughactivation  of  
key  enzyme  involved  in  gluconeogenesis,  principally  glucose 6-
phosphatase  and  phosphoenol piruvate carboxy kinase. In  peripheral  
tissue cortisol inhibit glucose uptake and utilization .in adipose tissue 
lipolysis is activated,  resulting  in   the release  of  free fatty  acids  in  to   
the circulation .  
  An  increase  in  the  circulating  cholesterol  and  triglycerides  
observed  but  HDL  cholesterol  levels  falls.  Glucocorticoids   also  
have  permissive  effect  on  other hormones  incuding  catecholamines  
and glucagone . the resultant  effect  to cause  insulin  resistance  and  an  
increase  in  blood  glucose  concentration  at the  expense  of  protein  
and  lipid  catabolism(7). 
 
 
 
Normal Pulsatile Secretion of 
Cortisol
 
 Cortisol in Normal Individual
 The hypothalamo-pituitary-adrenal axis 
 
 ACTH is the principle hormone stimulating adrenal corticoid 
biosysthesis and secretion.ACTH has 39 aminoacid sequence synthesized 
within anterior pituitary. ACTH secretion is tightly controlled by 
numerous factors; notably CRH and AVP (argeninvasopressin). 
Additional control is provided by an endogenous circadian rhythm, stress 
and feedback inhibition by Cortisol itself. CRH is a 41 amino acid that is 
synthesized in the hypothalamus and act on anterior pituitary to secrete 
ACTH(7). 
 
The hypothalamo-pituitary-adrenal axis 
 
   
 The proinflammatory cytokines notably IL-1,IL-6 and TNF 
alpha also increase ACTH secretion either directly or by augmenting the 
effect of CRH. Leukemia inhibiting factor a cytokine of IL-6 family is a 
further activator of HPA axis. This explains the response of HPA axis to 
an inflammatory stimulus, and is an important immune endocrine 
interaction. Physical stress increases ACTH and cortisol secretion again 
through central action mediated via CRH and AVP.Cortisol secretion 
rises in response to fever, surgery , burn injuries, hypoglycemia, 
hypotension and exercise,this can be viewed as a normal counter 
regulatory response to an insult. Depression is associated with high 
circulating Cortisol concentrations. The mechanism underlying elevated 
Cortisol level in diabetes is not known. Corticosteroid binding globulin 
levels are not elevated in diabetes(7).      
 
Coronary artery disease  
CAD is the most common form of heart   disease.  
 
It’s a spectrum  of disease ranging  stable angina, unstable and 
myocardial Infarction. Symptom complex may  occur  whenever  there  is   
an    Imbalance between   myocardial   Oxygen   supply   and   demand. 
Coronary   atheroma  by far  the  most   common   cause  of   angina  
although  the  symptom    may    be a   manifestation   of    other  forms   
of    heart    disease  particularly    aortic   valve disease  and hypertrophic  
cardiomyopathy. 
Atherothrombosis   is   no   longer considered as a   disease of   
developed    world    because myocardial Infarction and  stroke are  
increasingly  prevalent  worldwide.  By   2025   cardiovascular mortality 
on a  worldwide  scale  will   be  surpassed   that   of   every   major  
disease  group. 
From   an  epidemiological point of view a risk factor is a    
characteristic  or  feature  of  an  individual  or  population that is present 
in early life and is associated with an  increased risk of developing  future  
disease(9). 
The risk factor of Interest may be: 
1. Acquired behavior (smoking) 
  
2. Inherited trait (Familial Hyperlipedemia) 
 
3. Laboratory value (Cholesterol, C Reactive protein) 
For  a  risk  to  have clinical usefulness the marker of     interest    must    
predate  onset  of   disease.  Several  risk  factors such as  Hyperlipedemia   
and   hypertension   are   modifiable.  Trial    has demonstrated    that    
lowering    these    factors    reduces    vascular    risk. Although   it   
remains   controversial,  whether   markers  of   inflammation are     
directly     or     indirectly     associated     Atherothrombosis,   several 
inflammatory  markers  have  proved  highly effective in clinical practice 
for evaluating  vascular  risk. Not all  coronary  events  occur in 
individuals with traditional  risk factors.  In some individuals 
abnormalities of inflammation,haemeostasis / thrombosis  appears  to  
contribute decisively nearly half of MI and stroke occur among individual 
among Hyperlipedemia. 
 
Risk Factors  
 The role and relative importance of many   risk factors for the 
development of coronary, peripheral and cerebro vascular disease  have  
been  defined  in  animal studies and clinical interventional studies. The  
effect  of  risk  factors  is  multiplicative rather than additive. People with 
combination of risk factors are at greatest risk so assessment should take 
account of all identifiable risk factors
(9)
. 
Conventional risk factors  
 
1. Age/ Sex 
 
2. Family History 
 
3. Smoking 
 
4. Hypertension 
 
5. Hypercholestrolemia 
 
6. Diabetes mellitus 
 
7. Hemostatic factors 
 
8. Physical activity 
 
9. Obesity 
 
10. Alcohol 
 
11. Other dietary Factors 
 
12. Personality 
 
13. Social deprivation  
 
14. Mental stress(1) 
 
 
 
 
Age and Sex  
 Age is the most powerful independent risk factor  for CAD. 
Premenopausal  women  have  lower risk  of disease than men  although 
this   sex    difference   disappears    after   the   menopause.    Hormone 
replacement therapy has no role in the primary or secondary prevention 
of CAD. Isolated estrogen therapy may cause an increased cardiovascular 
event rate. 
 
Family History  
 CAD disease often runs in families due to combination of shared 
genetic, environmental  and life style factors. The most common inherited 
risk characteristics are polygenic. A positive family history is present 
when clinical problems in first degree relatives occur at relatively young 
age  such as less than 50 years for men and less than 55 years for women. 
 
Smoking  
 Probably   the   most   important   avoidable   cause   of    CAD.    
There is strong    consistent   and   dose   linked  relationship  between    
cigarette smoking  and  CAD,  especially  In  younger  individual less 
than 70  years. 35%-40% of all smokers die due to coronary artery 
disease. Persons who consume 20 or more cigarette daily have a 2 to 3 
fold increase in CAD. 
Consumption  of as few as   one   or  four cigaretts daily increase 
chance of coronary artery disease, such light level of smoking have a 
major impact on myocardial infarction and all cause mortality. 
Hypertension 
 The incidence of CAD increases as BP rises, as this excess risk  is 
related to both systolic and diastolic BP as well as pulse pressure. Anti  
hypertensive  therapy reduces cardiovascular mortality, stroke and heart  
failure. 
 
Hypercholestremia  
Risk increases with increase in serum cholesterol concentrations. 
Lowering serum cholesterol concentration reduces the risk o f CAD. 
 
Hypercholestrolemia ,increased level of LDL and reduced HDL 
increased risk of  CAD. 
 
Diabetes Mellitus 
 Potent  risk  factor  accounting  for  40%-50%  of  new cases  of   
CAD.  CAD  is  the  most  common cause of death in adults with DM. 
Insulin resistance is associated with obesity and physical inactivity is an  
important  risk  factor.  Hypothalamic  pituitary adrenal hyper activity 
may   underlie   metabolic   syndrome.   New   literatures   postulate  that 
elevated  cortisol  may  be  a  sole  risk  factor  for  CAD
(19)
. 
Haemostatic Factors 
 Platelet activation and high levels of fibrinogen are associated with 
increased risk of coronary thrombosis. Antiphospholipid antibodies are 
associated with recurrent arterial thrombosis. 
 
Physical Inactivity 
 Physical inactivity roughly doubles the risk of CAD  and is   a  
major   risk  factor  for  stroke.  Regular  exercise  has  a  protective effect   
which   may   be   related   to   increased   HDL    level    lower   BP and  
collateral   vessel  development. 
 
Obesity 
Obesity, particularly central or truncal in an independent risk 
factor. It is often associated with other adverse factors such as 
hypertension, diabetes and physical inactivity, hyperlipidemia. 
 
Alcohol 
Alcohol consumption is associated with reduced rate of CAD. 
Excess   alcohol   consumption   is   associated   with   hypertension   and 
cerebrovascular disease. 
 
 
 
Other dietary Factors 
 Diet  deficient  in  fresh  fruits  vegetables  and  PUFA are   
associated   with   increased   risk   of   CAD.   The  introduction  of 
Mediterranean style diet reduces CAD. Dietary supplements such as Vit 
C, Vit E, Beta-carotene, Folates and fish oils don’t reduce CAD and some 
cases have been associated with harm. 
 
Personality 
 Certain  personality  traits  are  associated  with  increased  risk  of 
CAD. Nevertheless there is little or no evidence to support the popular 
belief. 
 
Many patients with coronary artery disease seems to be compulsive 
driven, over achievers who are unable to relax and are quick to feel angry 
and frustrated when things do not proceed as planned. Those with type A 
behavior had significantly elevated rate of developing coronary artery 
disease in 5- 8 years follow up. Type B personality is unhurried , less 
aggressive and do not get upset when thwarted and have less chance of 
CAD
(9)
. 
 
 
 
Social deprivation  
 Health inequalities are a major cause of CAD. The impact of 
established risk  factors  amplified  in patients who are socially deprived 
the current guidelines  recommended that treatment thresholds should be 
lowered for  them.   
 
Mental stress 
 Both  depression and mental stress predispose to CAD. Adrenergic 
stimulation of mental stress can augment myocardial oxygen 
requirements   and  aggravate   myocardial  ischemia.  Mental  stress  can 
cause  coronary  vasoconstriction particularly in atherosclerotic coronary 
arteries  and  hence can influence myocardial oxygen supply. Depression 
may cause over activity of HPAA
(9)
. 
 
Depression 
 
Depressed Patients show hyper reactivity of HPAA and hyper 
cortisolemia and cortisol have atherogenic effects due to activation of pro 
inflammatory cytokines such as TNFalpha and IL-6 which may accelerate 
atherosclerosis. While acting classically as an antiinflammatory hormone  
cortisol excess can promote inflammation and accelerated atherosclerosis 
by producing insulin resistance changes in corticosteroid binding protein 
and regulation of pro inflammatory cytokines
(7)
. 
 
CAD Clinical Spectrum 
 
 Stable angina 
 Unstable angina 
 Myocardial Infarction 
 Heart failure 
 Arrhythmia 
 Sudden death 
 
Investigations 
 Resting ECG 
 Exercise ECG (Exercise tolerance test (ETT)) 
 Treadmill 
 Myocardial perfusion scanning 
 Coronary arteriography 
 Stress echo cardiography 
 
Management  
General Measures 
Carefully assess extent and severity of arterial disease , identify 
riskfactors such as smoking, hypertention , and hyperlipidemia .patient 
should be admitted urgently in case of MI and unstable angina because 
there is significant death rate or recurrent myocardial ischemia during the 
early unstable phase, and appropriate medical therapy can reduce the 
incidence of these by 60% . patients are usually managed in a dedicated 
cardiac unit where necessary expertise, monitoring, and resuscitation 
facilities can be concentrated. If there is no complications , the patient can 
be  mobilized from the second day and dischargedfrom hospital after3-5 
days. 
Antiplatelet therapy 
 In MI oral administration of 75- 300mg of aspirin improves 
survival ,with a 25% of relative risk reduction in mortality . first dose 
should be given orally within 12hours and therapy should be continued 
indefinitely if there is no side effects. 
 
Analgesia 
Adequate analgesia is essential not only to relieve distress but also 
lower adrenergic drive and there by reduce vascular resistance,BP, infarct 
size and susceptibility to ventricular arrhythmias. 
 
Antianginal drug treatment 
Sublingual glyceryl trinitrate 300- 500 micro gram is a valuable 
first aid measure in MI, which relieve pain ,reduce arrhythmia and 
improve short term mortality in patients who present within 12hours of 
the onset of symptoms. It should be avoided if there is hypotention or 
bradycardia. 
Trombolysis  
Promt trombolytic therapy within 12hours and particularly within  
6hours ,of the onset of symptoms reduces mortality in patients  with  
acute MI. 
Invasive Treatment     
 Percutaneous Coronary Intervention  
 Coronary Artery Bypass Grafting 
 
Lifestyle and risk factor modification 
 
Smoking 
 
5  years  mortality  of patients who continue to smoke cigarette is 
double that  of  those  who  quit  smoking  at  the  time  of  their  acute  
coronary syndrome. Giving up smoking is the single most effective 
contribution of a patient can make to his or her future. The success of 
smoking cessation can increase by supportive care and pharmacological 
therapy. 
 
Hyperlipedemia 
        HMGCoA  reductase enzyme  inhibitors can produce  marked           
reduction in total  cholesterol  and  reduce  the subsequent risk of death, 
reinfarction, stroke and the need for revascularization. 
 
 
Mobilization and rehabilitation  
Necrotic muscle of an acute MI takes 4 -6 weeks to be replaced by  
fibrous  tissue  and  it  is  conventional  to  restrict   physical   activities 
during    this  period.  When   there  is  no  complications  the  patient  can    
mobilize  on  2
nd
  day,  return  home   in  3-5 days  and  gradually  
increase  activity   with   the  aim  of   returning   to   work in  4-6 weeks.  
Emotional problems such  as  denial,  anxiety and depression are common 
and must be addressed. Many patients are severely and even permanently 
incapacitated as the  result  of  psychological  rather  physical  effects  of  
MI  and  all benefits from thoughtful  explanation, counseling  and  
reassurance  at  every   stage  of   illness. Many  patients  mistakenly  
believe  that stress was the cause of their heart attack and  restrict their 
activity inappropriately. The patients spouse or partner will also require  
emotional  support,  information  and  counseling.  Formal   rehabilitation 
programs   based   on   graded   exercise   protocols   with   individual   
and   group counseling  are  often  very  successful  and  in   some  cases  
have  been  shown to improve long term outcome(1). 
 
 Secondary prevention drug therapy  
Aspirin and clopidogrel 
Low dose aspirin herapy reduces the risk of further infarction and 
other vascular events by approximately 25% and should be continued 
indefinitely if there are no unwanted effects, clopidogrel should be  given 
in combination with aspirin for atleast 3 months. 
Beta blockers  
Continuous treatment with an oral beta blocker reduces the 
longterm mortality by approximately 25% among the survivors of acute 
MI . a minority of people do not tolerate beta blockers because of brady 
cardia, AVblock , hypotention , or asthma. 
 
ACE Inhibitors 
Several clinical trials have shown that longterm treatment with 
ACEInhibitors can counteract ventricular remodeling, prevent onset of 
heartfailure, improve survival, reduce recurrent MI and avoid 
rehospitalization. Benefits are greatest in those with overt heart failure. 
 
 
 Cortisol secretion in patients with Type 2 DM (relationship with 
chronic complications)  - American Diabetes association  
 
 In Type 2 diabetes subject’s cortisol secretion is associated with 
complication and metabolic control of diabetes. In the related study ADA 
evaluated 170 Type 2 Diabetic subjects, the presence of chronic 
complication like incipient nephropathy, asymptomatic neuropathy, silent 
macro angiopathy and hyperactivity of HPAA. The end of the study 
concluded that in Type 2 DM patients HPAA activity is enhanced and 
degree of cortisol secretion is related to the presence and number of 
diabetes complications. In patients with type 2 DM glucocorticoid 
secretion has been suggested to be a possible link between insulin 
resistance and features of metabolic syndrome (HT, Obesity, CAD, 
Hyperlipedemia and  
 Type 2 DM). While glucocorticoid excess has been demonstrated 
to lead to diabetes or worsen metabolic control the relationship between 
cortisol level, insulin resistance and chronic complications in Type 2 DM 
patient’s hypercorticolism is a matter of debate. In diabetic subjects 
without chronic complications HPAA axis activity was comparable with 
that of non diabetic patient, whereas in diabetic subjects with chronic 
complications cortisol level was increased. A trend for higher cortisol 
secretion in patients with either diabetic retinopathy or cardiovascular 
complication was found. Insulin resistance where comparable between 
diabetic subjects with or without diabetic complications and not 
associated with parameters of HPAA axis. So it is possible to speculate 
that an increased cortisol secretion may contribute to worsening the 
metabolic control of diabetes and insulin sensitivity. Possible effect of 
increased cortisol secretion in the pathogenesis of chronic diabetic 
complication is not mediated by insulin resistance. Further studies are 
needed to investigate possible causative role for cortisol secretion in the 
development of chronic complication of diabetes
(10- 14)
.  
 
 Cortisol , Testosterone and Coronary Heart Disease (prospective 
evidence from the Caerphilly Study  - American Heart Association  
 
 There is a popular belief that chronic stress causes heart disease 
through psyconeuroendocrine mechanism. Specific association between 
cortisol testosterone ratio and incidence of ischemic heart disease 
apparently mediated through insulin resistance syndrome. Whether this 
reflex effects of chronic stress behavioral factors or genetic influences 
remains to be determined.Neuroendocrine have been viewed as a central 
component of stress response. Stress suppresses testosterone levels which 
appear to be a consequence of cortisol elevation. Glucocorticoid 
suppresses testosterone in men and low testosterone levels are a central 
component of chronic physical and psychological stress response in men. 
A high ratio of cortisol and testosterone levels has been widely used as 
endocrinological indicators of stress in human studies. A higher cortisol 
testosterone ratio was associated with younger age, higher fibrinogen 
levels and smokers. More favorable socioeconomic position was 
associated with higher cortisol testosterone ratio. But it was not seen in 
parental social class. Among drinkers cortisol testosterone ratio increased 
with amount of alcohol consumed. CADmortality and incidence 
positively associated with cortisol testosterone ratio. There is no 
association of cortisol testosterone ratio withnon CADmortality in DM 
patients. Cortisol is a potential mediator between stress and 
cardiovascular disease. Endogenous testosterone levels have also been 
related to fasting glucose and insulin concentration and can predict the 
onset of Type 2DM. Cortisol and testosterone secretion are inter related. 
Activation of HPAA not only results in an elevation of adrenal cortical 
steroids but also inhibit gonadotropin secretion. Cortisol testosterone ratio 
is associated with a specific elevation in CAD risk that was robust to the 
adjustments for potential confounding factors but appeared attributable to 
components of Insulin resistance syndrome. Evidence from various 
sources suggest that high cortisol and low testosterone levels are 
associated with worse profile of Insulin resistance components and 
modifications like testosterone supplementation improves this pattern. 
This suggests that methods of reducing CT ratio may improve Insulin 
resistance and reduce the risk of coronary arterial disease (15-16). 
 
Correlation between HPAA and the metabolic syndrome 
The metabolic syndrome has several similarities with Cushing 
Syndrome (impaired glucose tolerance, HTN, dyslipedemia, central 
Obesity) suggesting that abnormalities in the regulation of HPAA may 
have a link with metabolic syndrome. Several studies suggested an 
association between clinical signs of metabolic syndrome and increase 
HPAA activity based on increased cortisol concentration at 9 am and 
increase cortisol response to corticotrophin. According to Barker 
hypothesis fetal malnutrition could determine adult cardiovascular 
disease and endocrine metabolic disorders (Obesity, type II DM, 
Hyperlipedemia). The suggested mechanism of phenomenon is that the 
suboptimal fetal nutrition results in glucocorticoid over production. The 
11 beta hydroxyl steroid dehydrogenase is an important enzyme in 
cortisol metabolism. The increased expression of 11 beta hydroxyl steroid 
dehydrogenase in fat tissue could lead to central obesity and impaired 
glucose tolerance. The hypothesis that increase CRH production drives 
the over active HPAA was not proven
(19)
. 
 
  
 
 Elevated Plasma Cortisol Concentration : A link between low birth 
weight and Insulin resistance Sydrome - Journal of Clinical 
Endocrinology and Metabolism 
 
 Recent studies have shown that reduced fetal growth is associated 
with development of Insulin resistance syndrome in adult life. The 
mechanism was not known however increased activity of HPAA may 
underlie this association. Studies in both Europe and North America have 
shown that low birth weight is associated with increased rates of CAD in 
adult life. It is well established that environmental exposure in prenatal 
and early post natal life may result in permanent modification of 
neuroendocrine modification of stress throughout life(17). 
 Circulating plasma cortisol concentration is not associated with 
coronary artery disease or peripheral vascular disease                        
- Oxford Journal of Medicine (Qjm) 
 
  Study conducted to determine whether basal circulating cortisol 
level predict CAD or PVD. Background of this study was obesity 
epidemic with associated metabolic syndrome may increase the 
prevalence of cardiovascular disease. Conclusion of the study was single 
measurement of Cortisol is a poor predictor of vascular disease. More 
detailed charactrisation of the HPAA is necessary to determine the role of 
circulating endogenous Glucocorticoids and there responsiveness to stress 
in atherosclerosis
(18)
. 
Elevated fasting plasma Cortisol is associated with ischemic heart 
disease and its risk factors in people with type 2diabetes : The 
Edinburgh Type 2 Diabetes Study   
 
The Edinburgh Type 2 diabetes study is a prospective study 
investigating mechanism and risk actors for diabetes related cognitive 
decline and or the development and progression of micro and macro 
vascular disease in diabetes. 
 
 Context of the study was increased activity of HPAA may underlie 
metabolic syndrome but whether circulating plasma Cortisol level predict 
cardiovascular endpoint is less clear. Selected people with Type 2 DM are 
at increased risk of cardiovascular complication and thus are suitable to 
study the association of plasma Cortisol with cardiovascular risk. 
Elevated plasma Cortisol level measured in the morning has been 
described in the individuals with glucose intolerance, HTN and 
dyslipedemia. This has been associated with alteration in the regulation of 
the HPAA. In people with diabetes, early studies of HPAA regulation 
showed inconsistencies this was partially caused by inclusion of 
individuals with Type 1 DM. the summary and conclusion of study says 
the previously described association between HPAA activation and 
metabolic syndrome are evident in people with Type 2 DM. Elevated 
plasma Cortisol are also associated with greater prevalence o ischemic 
heart disease in people with Type 2 DM
(19)
.                                                            
Design Methodology Techniques 
 The study was conducted at Coimbatore Medical Hospital, 
Coimbatore during period of September 2009 to September 2010. 50 
patients of Type 2DM were included in the study. No patients had been 
counted if he/she got admitted again after discharge during this period.  
 
Design of study 
 Cross sectional study  
 
Methodology 
 50 Type 2DM patients who got admitted in Coimbatore Medical 
College, Hospital were included in the study. 50 consecutive were 
recorded.  
 In those patients BP, Waist Circumference, Blood Glucose Levels, 
Lipid profile, fasting cortisol level and Urine Protein were measured and 
ECG, Echocardiogram was taken to study whether there is an increased 
association of cortisol level with prevalence of coronary artery disease in 
patients with Type 2DM. 
Why Type 2DM patients are involved in the study?  
            In Type 2DM the chance of CAD and hyperactive HPAA is more 
thus easy to study the association in these patients. 
 
Inclusion Criteria  
 
1. Type 2 DM Patients 
2. Age group above 50 years 
3. Both Sexes 
4. First Admission      
Exclusion Criteria 
            1. Cushing disease / Syndrome 
            2. Patients who are on steroid treatment 
            3. Age group below 50 years         
 
Diagnosis of Diabetes Mellitus  
1. Random  Blood  Glucose  Concentration  more  than  200 mg 
%(>11.1mmol/L) 
2. Fasting Glucose more than 126 mg % (>7mmol/L) 
3. Two hour plasma glucose more than 200 mg %(>11.1mmol/L) 
during an oral GTT. 
 Dignosis of Coronary Artery Disease 
1. Symptoms Like angina and anginal equivalents. 
2. ECG  
3. ECHO 
 
ECG Recording:        
 12 lead ECG was taken or all the cases;It was standardized to 
produce deflection of 10mm/1mvolt in put and paper speed was set 25 
mm / sec. Changes of for coronary artery Disease were noted. It includes 
1. T Wave changes 
2. ST changes 
3. Bundle branch block  
ECHO Cardiography 
M MODE 2D ECHO was done in all patients. 
1. Rhythm of Heart noted 
2. Regional wall motion abnormality 
3. Papillary muscle dysfunction 
4. Systolic / Diastolic function 
CORTISOL MEASUREMENT 
 Fasting cortisol level was measured after 8-10hours of fasting. 
 Normal fasting cortisol – 5-25 microgram/dl 
 
 
 
 
SEX DISTRIBUTION 
 
 
MALE: 52% 
                                     
            
FEMALE: 48% 
Out of 50 patients of type 2 diabets was studied 48% was females and 
52% was males. 
 
 
 
AGE DISTRIBUTION 
 
 
50-60 YEARS :            50% 
 
60-70 YEARS :                       42% 
 
>70 YEARS :                   8% 
Out of 50 patients of type 2 DM studied 50% was in the age group of 50-
60 years, 42% was in between 60-70% and only 8% patients contributes 
> 70 years 
       
 
TYPE 2 DM PATIENTS WITH CAD 
 
without CAD                            54%        
with CAD                                   46% 
Out of 50 of type 2 DM patients 54% was without coronary artery disease 
and 46% patients was associated with CAD.  
 
 
CORTISOL DISTRIBUTION IN TYPE 2 
DM
 
ELEVATED CORTISOL    20% 
NORMAL CORTISOL      80%   
Out of 50 type 2 DM patients studied, 10 showed elevated fasting cortisol 
level; rest were normal. 
 
AGE AND CORTISOL 
Crosstab
21 4 25
84.0% 16.0% 100.0%
52.5% 40.0% 50.0%
16 5 21
76.2% 23.8% 100.0%
40.0% 50.0% 42.0%
3 1 4
75.0% 25.0% 100.0%
7.5% 10.0% 8.0%
40 10 50
80.0% 20.0% 100.0%
100.0% 100.0% 100.0%
Count
% within Age
% within Fasting Cortisol
Count
% within Age
% within Fasting Cortisol
Count
% within Age
% within Fasting Cortisol
Count
% within Age
% within Fasting Cortisol
Less than 60 years
Between 60 - 70 years
Above 70 years
Age
Total
Normal Elevated
Fasting Cortisol
Total
 
 
In above table P value is .77 so > more than .05, it shows that there 
is no association between age and elevated cortisol. 
Fasting Cortisol * CAD Crosstabulation
25 15 40
62.5% 37.5% 100.0%
92.6% 65.2% 80.0%
2 8 10
20.0% 80.0% 100.0%
7.4% 34.8% 20.0%
27 23 50
54.0% 46.0% 100.0%
100.0% 100.0% 100.0%
Count
% within Fasting Cortisol
% within CAD
Count
% within Fasting Cortisol
% within CAD
Count
% within Fasting Cortisol
% within CAD
Normal
Elevated
Fasting Cortisol
Total
Absent Present
CAD
Total
 
 
In an attempt to study the association of cortisol level and coronary artery 
disease, out of 50 patients studied, 10 patients showed elevated cortisol, 
40 patients had normal cortisol level. Out of 50 patients studied,23 had 
coronary artery disease. Among 10 patients with elevated cortisol,8 were 
associated with coronary artery disease. 
 From the above table it can be concluded that the association 
between elevated fasting cortisol level and coronary artery disease is 
significant (p value < 0.05). 
It means that in patients with elevated fasting cortisol level, there is 
an increased chance of coronary artery disease. 
 
 
 
Chi-Square Tests
5.817b 1 .016
4.232 1 .040
6.061 1 .014
.030 .019
5.701 1 .017
50
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
1 cells (25.0%) have expected count less than 5. The minimum expected count is 4.
60.
b. 
  
 
 
 
 
Discussion                        
 
DISCUSSION 
An attempt has been made to study fifty cases of type 2 diabetes 
mellitus to study the association of cortisol level and coronary artery 
disease. In the cohort of 50 diabetic patients 23 had coronary artery 
disease, which comes to 46% of total patients. In the 50 type 2 diabetic 
patients, 22% had acute coronary syndrome; 24% had ischemic heart 
disease. 
 
           The Framingham Heart study revealed a marked increase in 
congestive  heart failure, coronary artery disease and sudden cardiac 
death in type 2 diabetes mellitus patients(The risk increases from one to 
five fold in DM).The American Heart association has designated DM as a 
major risk factor for cardiovascular disease
(2)
. 
 
Among 50 DM patients, 52% were males and 48% were females. 
According to the Centre for Disease Control and Prevention (CDC), the 
prevalence of DM is similar in men and women throughout most age 
ranges but is slightly greater in men more than 60 years
(2)
. 
 
            Conventional risk factors for coronary artery disease are diabetes 
mellitus, systemic hypertension, dyslipedemia, etc. Diabetes mellitus is 
the major risk  factor for coronary artery disease. Newly proposed theory 
is that there is an  overactivity of hypothalamopituitary adrenal axis and 
elevated cortisol level
(19)
.  
 
Elevated cortisol is a single risk factor for coronary artery disease. 
According to Edinburg type 2 diabetes study, type 2 diabetic patients 
have hyperactive hypothalamopituitary adrenal axis and have elevated 
cortisol level and it was concluded that there is an increased chance of 
metabolic syndrome and coronary artery disease in patients with elevated 
cortisol level. 
 
              Out of 50 diabetic patients, 10 patients had elevated cortisol 
level.8 out of 10 patients with elevated level had coronary artery disease. 
This shows that there is  an association between elevated cortisol level 
and coronary artery disease
(19)
.  
 
              In our population, cortisol is only moderately elevated. Also, 
cortisol is elevated in patients who are having more than one 
complication of diabetes like  dyslipedemia, central obesity, proteinuria 
and hypertension. Also, there is an association between elevated cortisol 
and coronary artery disease.  
 
 
     
  
 
 
 
 
 
 
 
 
 
 
Conclusions           
CONCLUSION 
 
 There is hyperactivity of hypothalamopituitary axis in type 2 DM 
patients. Out of 50 patients,10 had mild to moderate elevation of 
fasting serum Cortisol. 
 
 There is an association of elevated cortisol and high prevalence of 
coronary artery disease in patients with type 2 DM. 
 
 Further studies are needed to find out the mechanism of 
hypothalamopituitary axis overactivity. 
 
 Further studies are needed to find out the pathogenesis behind 
elevated cortisol causing coronary artery disease. 
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PROFORMA 
STUDY TO ANALYZE THE ASSOCIATION OF CORTISOL LEVEL AND 
CORONARY 
ARTERY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 
 
NAME:                              AGE:                       SEX:                                 
ADDRESS: 
 
 
 
 
 
 
              
                  
 
     
 
 
 
 
            PULSE 
 
 
               BP  
               WC  
               HT  
               WT  
 
        SYMPTOM 
 
              SIGN 
 
       POLYURIA 
 
 
    PEDAL OEDEMA 
 
      POLYDYPSIA 
 
 
          PULSE 
 
     POLYPHAGIA 
 
 
             BP 
    
      CHEST  PAIN 
 
     EXERTIONAL 
BREATHLESSNESS   
INVESTIGATIONS  
RBS  
FBS  
PPBS  
FASTING LIPD         
PROFILE 
 
FASTING 
CORTISOL 
 
          CVS  
          RS  
          CNS  
          ABD  
      ECHO  
       ECG  

ABBREVIATIONS 
 
ACTH    Adreno Corticotropic Hormone 
AGE     Advanced Glycation Endproducts 
ASMI    Anteroseptal Myocardial Infarction 
ATP     Adult Treatment Panel 
AVP     Arginin Vasopressin    
AWMI    Anterior Wall Myocardial Infarction 
BP     Blood Pressure 
CAD     Coronary artery Disease 
DM     Diabetes Mellitus 
ECM     Extra Cellular Matrix 
EF     Ejection Fraction 
FBS     Fasting Blood Sugar 
HDL     High Density Lipo Protein 
HLMI    High Lateral Wall Myocardial Infarction 
HPAA    Hypothalamo Pituitary Adrenal Axis 
IL     Interleukin 
MMP     Matrix Metallo Proteinase 
PR     Pulse Rate 
PPBS     Post Prandial Blood Sugar 
RBS     Random Blood Sugar 
RWMA    Regional Wall Motion Abnormality 
SHT / SHTN   Systemic Hypertension 
WC     Waist Circumference 
CONSENT FORM 
Yourself Mr/Mrs/Ms  _________________ are  being asked to be a 
participant in the study titled – STUDY TO  ANALYZE  THE  
ASSOCIATION  OF  CORTISOL  LEVEL  AND  PREVALENCE  
OF  CORONARY ARTERY  DISEASE  IN  PATIENTS  WITH  
TYPE  2 DIABETES MELLITUS by Dr Aryamol M.K, Post Graduate 
student, Department of General Medicine,Coimbatore Medical College. 
You are eligible after looking into inclusion  criteria. You can ask any 
questions you may have  before  agreeing to participate.  
 
Purpose of the research  
To  analyze  the  association  of  cortisol  level  and  prevalence  of  
coronary artery  disease  in  patients  with  type  2 diabetes mellitus 
 
Procedures involved  
This research is intended to study type 2 daiabetes mellitus patients and to 
analyse the association of cortisol level and prevalence of coronary 
disease in these patients.  
 
Decline from participation  
You have the option to decline from participation in the study without 
any discrimination and you will be treated as per the existing protocol for 
your condition. 
Privacy and confidentiality  
Privacy of individual will be respected and any information about you or  
provided by you during the study will be kept strictly confidential. 
 
Authorization publish results  
Results of the study may be published for scientific purposes and / or  
presented to scientific groups; however you will not be identified. 
 
Statement of Consent   
I volunteer and consent to participate in this study. I have read the 
consent or it has been read to me. The study has been fully explained to 
me and I may ask questions at any time.  
________________________________           _______________  
Signature of Left Hand thumb Impression         Date  
(Volunteer Subject)       
______________________________    ________________  
Signature (Witness)                                          Date  
                                                      
 
 
